Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
73.15
-0.66 (-0.89%)
Nov 22, 2024, 4:00 PM EST - Market closed

Insmed Revenue

Insmed had revenue of $93.43M in the quarter ending September 30, 2024, with 18.15% growth. This brings the company's revenue in the last twelve months to $342.96M, up 22.13% year-over-year. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.

Revenue (ttm)
$342.96M
Revenue Growth
+22.13%
P/S Ratio
33.16
Revenue / Employee
$376,050
Employees
912
Market Cap
13.09B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG 21.46B
Tenet Healthcare 20.97B
Universal Health Services 15.42B
DaVita 12.67B
Solventum 8.22B
Incyte 4.08B
Genmab 2.97B
BioMarin Pharmaceutical 2.75B
Revenue Rankings